Search

everythinglearnresearchcommunity

for

Search:↓

17-β estradiol and prednisolone may speed up hair regrowth after chemotherapy.

Lower testosterone levels may increase heart failure risk in older men.

Blocking the KATP channel may help treat migraines.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Microneedles improve drug delivery, patient compliance, and have potential in cancer treatment and skin care.

Adipose tissue-derived therapies show promise for improving osteoarthritis symptoms but need more research for safety and effectiveness.

Olorofim effectively treats fungal skin infections.

Increased methylation of the Filip1l gene may contribute to aggressive skin cancer.

Laser-Assisted Exosome Delivery showed early skin improvement without side effects, but more research is needed.

Marine biomaterials show promise for drug delivery and wound healing.

Antiandrogens don't help with COVID-19 and aren't recommended.

Using three different drugs together may better treat eye diseases like glaucoma and macular degeneration.

Mercury exposure damages small nerve fibers in rats' skin.

Ritlecitinib is safe and may effectively treat alopecia areata.

Some medications and supplements can affect male fertility, with some improving and others harming sperm quality.

New treatments for seborrheic dermatitis show promise for difficult cases.

Cannabinoids like CBD and THC may help treat non-cancer skin diseases, but more research is needed.

Dutasteride helps reduce heavy drinking, especially for those who drink to cope.

New skin disease treatments using TDDS are improving but face challenges like side effects and high costs.

Linkus cough syrup is effective and safe with no side effects or toxicity in rats.

Interleukin-15 can help hair growth and protect hair follicles.

Exosome-based therapies in dermatology show promise but face challenges in standardization, regulation, and safety.

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

Organoids and hair-on-chip technologies show promise for hair regeneration but face clinical challenges.

Lowering HER2 levels with certain drugs may reduce metabolic syndrome risk in women.

Personalized skin rejuvenation using genomics shows promise but needs more research.

Exosome therapy shows promise for treating hair loss, but needs standardized protocols and further trials.

Synthetic curcumin derivatives improve treatment for diabetes and cancer.